Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
Demonstrated or suggested benefit | Inconclusive results | Uncertain results | Safety results | |||
mavrilimumab | 0 | - | - | - | - | |
Namilumab | 0 | - | - | - | - | |
otilimab | 0 | - | - | - | - |